News
September 3, 2021 Event
Have you missed Obliques’ presentation
during the Pareto Securities’ Healthcare Conference 2021?
September 1, 2021 News
Our Founder & CEO Prof. Owe Orwar has been named a winner
in the CEO Today Healthcare Awards for 2021 by CEO Today Magazine.
August 30, 2021 Event
For the 1st Neuropathic Pain Therapeutics Summit
our Head of Discovery & Preclinical R&D- Ion Channel Target in Pain – Daniela Papadia was invited as Expert Speaker.
June 18, 2021 News
Annual General Meeting On Wednesday the 15th of June 2021,
we held our Annual General Meeting to conclude our year and discuss about the future. Exciting time.
April 26, 2021 News
The prestigious Shanghai ranking gives at Karolinska Institutet
the fifth position in the world of the best Departments of Pharmacology worldwide.
April 19, 2021 News
Science Advances, has published a research article
describing our proteomics technology AbiProt®, a high-tech antibody discovery approach with the potential to bring several novel antibody medicines to large patient populations in multiple disease areas.
March 11, 2021 Event
On March 10th 2021, Professor Owe Orwar, CEO
presented Oblique Therapeutics AB at Carnegie Nordic Virtual Healthcare Seminar 2021.
November 18, 2020 News
Oblique Therapeutics AB raises 98 MSEK
in a private placement investment round.
October 19, 2020 News
This is our first Abiprot patent.
We hope that many more will follow.
October 8, 2020 News
Oblique Therapeutics AB together with collaborators
at Sahlgrenska University Hospital (Gothenburg) and Karolinska Institutet (Stockholm) has been granted 5MSEK.